An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

JOURNAL ARTICLE published November 2010 in Clinical Pharmacology & Therapeutics

Authors: B C Goh | N J Reddy | U B Dandamudi | K H Laubscher | T Peckham | J P Hodge | A B Suttle | T Arumugham | Y Xu | C-F Xu | J Lager | M M Dar | L D Lewis